Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc …

San Diego, CA (PRWEB) July 25, 2014

WABC Radio show out of New York City, A Paws For Your Pet with Lorry Young will be hosting California-based Vet-Stem, Inc.s Founder and CEO, Robert J. Harman, DVM, to talk about stem cell therapy in pets. Dr. Harman first visited the show in November 2013 to discuss the benefits of stem cell therapy for pets suffering from osteoarthritis and other degenerative diseases, as well as recent developments moving the Regenerative Veterinary Medicine industry forward.

Young has invited Dr. Harman back to dial down into specific case studies and success stories of the over 10,000 dogs, cats, horses and exotic animals that Vet-Stems services have treated in the last decade. Moose, a Labrador Retriever Mix, is one of those special pet patients in the New York City area that was treated with Vet-Stem Regenerative Cell Therapy for arthritis caused by elbow dysplasia, and arthritic bone growth.

When Mooses owners noticed decreased mobility, lameness, and an increasingly lower tolerance for other dogs they brought Moose to local veterinarian Alex Klein to explore solutions. As many as 65% of dogs between the ages of 7 and 11 years old are inflicted with some degree of arthritis. Certain specific breeds, much like Moose, are reported to have as high of a percentage as 70 in being diagnosed with arthritis.

Stem cell therapy has been proven to help with the pain of arthritis in pets because it decreases inflammation, regenerates damaged tissues, and restores range of motion. An owner survey showed that greater than 80% of dogs treated for osteoarthritis in one or more leg joints with Vet-Stem Regenerative Cell Therapy showed an improved quality of life. Dogs like Moose have a small amount of fat collected by their veterinarian, which is sent overnight to Vet-Stems lab. There, the fat is separated from the stem cells and injectable doses of concentrated stem cells are sent back to the veterinarian overnight. Within 48 hours Moose received injections in his arthritic joints and the healing process began.

This ability to improve on a pets quality of life is why Dr. Harman is so passionate about sharing stories with other animal enthusiasts such as Young and her radio audience. Pet-spert, Young offers a special look into the latest techniques, treatments, and options that will enable listeners to provide their pets with a safer, healthier, and happier life. Produced and hosted by Young, A Paws For Your Pet, helps listeners answer any potential questions they may have regarding the health and well-being of their beloved pet, and hosts experts in the industry like Dr. Harman regularly.

About Vet-Stem, Inc. Since its formation in 2002, Vet-Stem, Inc. has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem pioneered the use of regenerative stem cells for horses, dogs, cats, and some exotics. In 2004 the first horse was treated with Vet-Stem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. Ten years later Vet-Stem celebrated its 10,000th animal treated, and the success of establishing stem cell therapy as a proven regenerative medicine for certain inflammatory, degenerative, and arthritic diseases. As animal advocates, veterinarians, veterinary technicians, and cell biologists, the team at Vet-Stem tasks themselves with the responsibility of discovering, refining, and bringing to market innovative medical therapies that utilize the bodys own healing and regenerative cells. For more information about Vet-Stem and Regenerative Veterinary Medicine visit http://www.vet-stem.com or call 858-748-2004.

Go here to read the rest:
Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc …

'Most stem cell-based cosmetic surgeries fake'

Washington, July 30 (IANS) Next time you come across an advertisement offering cosmetic stem cell procedures not only to give your skin a glowing look but also to stop it from growing old, beware. Most of such ads claim benefits from procedures that have not undergone rigorous scientific evaluation – including potential risks related to stem cell and tissue processing and the effects of ageing …

See the rest here:
'Most stem cell-based cosmetic surgeries fake'

Stem cell discovery may make tissue regeneration more efficient

A new stem-cell discovery might one day lead to a more streamlined process for obtaining stem cells, which in turn could be used in the development of replacement tissue for failing body parts, according to UC San Francisco scientists who reported the findings in the current edition of Cell.

The work builds on a strategy that involves reprogramming adult cells back to an embryonic state in which they again have the potential to become any type of cell.

The efficiency of this process may soon increase thanks to the scientists identification of biochemical pathways that can inhibit the necessary reprogramming of gene activity in adult human cells. Removing these barriers increased the efficiency of stem-cell production, the researchers found.

Our new work has important implications for both regenerative medicine and cancer research, said Miguel Ramalho-Santos, Ph.D., associate professor of obstetrics, gynecology and reproductive sciences and a member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, who led the research, funded in part by a prestigious NIH Directors New Innovator Award.

The earlier discovery that it was possible to take specialized adult cells and reverse the developmental clock to strip the mature cells of their distinctive identities and characteristics and to make them immortal, reprogrammable cells that theoretically can be used to replace any tissue type led to a share of the Nobel Prize in Physiology or Medicine being awarded to UCSF, Gladstone Institutes and Kyoto University researcher Shinya Yamanaka, M.D., in 2012.

These induced pluripotent stem (iPS) cells are regarded as an alternative experimental approach to ongoing efforts to develop tissue from stem cells obtained from early-stage human embryos. However, despite the promise of iPS cells and the excitement surrounding iPS research, the percentage of adult cells successfully converted to iPS cells is typically low, and the resultant cells often retain traces of their earlier lives as specialized cells.

Researchers generate stem cells by forcing the activation within adult cells of pluripotency-inducing genes starting with the so-called Yamanaka factors a process that turns back the clock on cellular maturation.

Yet, as Ramalho-Santos notes, From the time of the discovery of iPS cells, it was appreciated that the specialized cells from which they are derived are not a blank slate. They express their own genes that may resist or counter reprogramming.

But the nature of what exactly was getting in the way of reprogramming remained poorly understood. Now, by genetically removing multiple barriers to reprogramming, we have found that the efficiency of generation of iPS cells can be greatly increased, he said. The discovery will contribute to accelerating the safe and efficient use of iPS cells and other reprogrammed cells, according to Ramalho-Santos.

Miguel Ramalho-Santos

Read more here:
Stem cell discovery may make tissue regeneration more efficient

Bacardis Make Gift to Significantly Advance Mayo Clinic's Regenerative Medicine Research

Released: 29-Jul-2014 8:00 AM EDT Source Newsroom: Mayo Clinic Contact Information

Available for logged-in reporters only

Newswise JACKSONVILLE, Fla. Imagine a future in which a new lung is grown for a patient in need, using the patients own cellular material, or a day when an injection of replacement cells will enable a patient to self-heal damage in the brain, nerves or other tissues.

MULTIMEDIA ALERT: For audio and video of Dr. Keller and Jorge Bacardi talking about the gift and regenerative medicine, visit the Mayo Clinic News Network.

Regenerative medicine is no longer science fiction, and a substantial gift from Jorge and Leslie Bacardi of the Bahamas will significantly accelerate the research of Mayo Clinics Center for Regenerative Medicine on the Florida campus.

Jorge Bacardi, whose family has manufactured rum and other spirits for 150 years, suffered since childhood with primary ciliary dyskinesia, a debilitating lung disease that nearly ended his life. A double lung transplant at Mayos Florida campus in 2008 enabled him to take his first full breath of air at age 64.

Regenerative medicine is an extraordinary step in the evolution of mankind, says Jorge Bacardi. It is for Leslie and I a great honor to be able to join Mayo Clinic in the development of such an advancement in the medical field.”

Regenerative medicine is addressing the root causes of disease and disability by developing ways to rejuvenate the body using its natural self-healing processes; replace damaged cells with healthy ones derived from the patient (avoiding immune system rejection); and regenerate function by applying specific cells or cell products.

Mayos regenerative medicine researchers are targeting conditions throughout the body, including heart disease, stroke, Alzheimers disease and traumatic injuries that affect combat veterans. Some studies are in the earliest stages. Others are in clinical trials with patients.

Researchers now can differentiate stem cells into skin, brain, lung and many other types of cells. For example, a patient’s own skin cells may be collected, reprogrammed in a laboratory to give them certain characteristics, and then delivered back to the patient to treat diseases at various places within the body.

See the original post here:
Bacardis Make Gift to Significantly Advance Mayo Clinic's Regenerative Medicine Research

Heal Interstitial Cystitis with Stem Cell Therapy – Video



Heal Interstitial Cystitis with Stem Cell Therapy
via YouTube Capture.

By: Minecraft madness and mayhem

Go here to read the rest:
Heal Interstitial Cystitis with Stem Cell Therapy – Video

Spouse of Lung Institute patient on NBC Daytime – Video



Spouse of Lung Institute patient on NBC Daytime
Terry Jo Gile, spouse of a Lung Institute patient along with Dr. Burton Feinerman of the Lung Institute speak with CBS Daytime about how stem cell therapy was used to treat her husbands Lung Disease.

By: Lung Institute

Continue reading here:
Spouse of Lung Institute patient on NBC Daytime – Video

Stem Cell Treatment for Shoulder Pain – Video



Stem Cell Treatment for Shoulder Pain
To learn more about San Diego shoulder surgery, visit orthopedicsurgerysandiego.com.

By: ClientSiteVideos

See the original post:
Stem Cell Treatment for Shoulder Pain – Video

acupuncture treatment for diabetes, permanent treatment for diabetes, stem cell treatment diabetes – Video



acupuncture treatment for diabetes, permanent treatment for diabetes, stem cell treatment diabetes
DOWNLOAD LINK :- http://tinyurl.com/nuj95lv , Learn a Little-Known, But 100% Scientifically-Proven Way To ERASE Your Diabetes in 3 SHORT weeks…, READ MORE @ http://tinyurl.com/nuj95lv …

By: Raja Koppula

Read this article:
acupuncture treatment for diabetes, permanent treatment for diabetes, stem cell treatment diabetes – Video

treatment for type 1 diabetes mellitus, diabetes type 1 stem cell treatment, acupressure treatment – Video



treatment for type 1 diabetes mellitus, diabetes type 1 stem cell treatment, acupressure treatment
DOWNLOAD LINK :- http://tinyurl.com/nuj95lv , Learn a Little-Known, But 100% Scientifically-Proven Way To ERASE Your Diabetes in 3 SHORT weeks…, READ MORE …

By: Raja Koppula

Read more:
treatment for type 1 diabetes mellitus, diabetes type 1 stem cell treatment, acupressure treatment – Video

Fate Therapeutics Announces FDA Clearance of IND for Clinical Development of PROHEMA in Inherited Metabolic Disorders

SAN DIEGO — Fate Therapeutics, Inc. , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that the U.S. Food and …

Read more:
Fate Therapeutics Announces FDA Clearance of IND for Clinical Development of PROHEMA in Inherited Metabolic Disorders